Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
20.40
-0.52 (-2.49%)
At close: Jun 12, 2025, 4:00 PM
20.40
0.00 (0.00%)
After-hours: Jun 12, 2025, 5:45 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $290.95 million as of June 12, 2025. Its market cap has decreased by -30.20% in one year.
Market Cap
290.95M
Enterprise Value
22.74M
1-Year Change
-30.20%
Ranking
Category
Stock Price
$20.40
Market Cap Chart
Since March 7, 2014, Neurogene's market cap has increased from $114.10M to $290.95M, an increase of 154.99%. That is a compound annual growth rate of 8.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2025 | 298.40M | -12.13% |
| Dec 31, 2024 | 339.60M | 646.37% |
| Dec 29, 2023 | 45.50M | 109.68% |
| Dec 30, 2022 | 21.70M | -89.39% |
| Dec 31, 2021 | 204.50M | -65.38% |
| Dec 31, 2020 | 590.70M | 25.07% |
| Dec 31, 2019 | 472.30M | 829.72% |
| Dec 31, 2018 | 50.80M | -81.59% |
| Dec 29, 2017 | 275.90M | -28.65% |
| Dec 30, 2016 | 386.70M | 80.03% |
| Dec 31, 2015 | 214.80M | 167.83% |
| Dec 31, 2014 | 80.20M | -29.71% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 732.75B |
| Johnson & Johnson | 375.03B |
| Novo Nordisk | 353.21B |
| AbbVie | 340.58B |
| UnitedHealth Group | 283.93B |
| Abbott Laboratories | 236.93B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |